Skip to main content
Log in

Influence of short- and long-term inhalation of salbutamol on lung function and β2-andrenoceptors of mononuclear blood cells in asthmatic children

  • Pneumology
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Clinical observations have shown that some asthma patients develop tachyphylaxis to β-sympathomimetic drugs. As down-regulation of the number of β-adrenoceptors in different human tissues after exposure to catecholamines and β-adrenergic drugs is well known, we investigated whether a interrelation exists between β-adrenoceptor down-regulation and clinically detectable β-adrenergic subsensitivity during β-sympathomimetic treatment. The following results were obtained: 1. β2-Sympathomimetic inhalation treatment with salbutamol in therapeutic doses led to a significant downregulation of β2-adrenoceptors and consecutive cyclic adenosine monophosphate response to isoprenaline. This effect was already detectable after short-term treatment of 3–7 days in 9 asthmatic children. 2. In the long-term study over 6 months, salbutamol inhalation in 12 asthmatic children led to a significant down-regulation of β-adrenoceptor binding sites on mononuclear blood cells (MNC) from 1539±91 to 1115±99 after 14 days, remaining in this range thereafter. 3. The mean airway resistance (Raw) of these 12 patients decreased significantly within 14 days from 8.1±0.8 to 5.7±0.5 cm H2O/l/s to remain stable throughout the 6 months of salbutamol treatment. The differences in Raw before and immediately after inhalation of 0.2 mg salbutamol (2 puffs) were unchanged during the study period. It is concluded, that long-term inhalative treatment with salbutamol over a period of 6 months does not result in refractoriness to β-adrenergic drugs in the airways of asthmatic children, even though a significant down-regulation of β2-receptors on peripheral MNC occurs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

cAMP:

cyclic adenosine monophosphate

ICYP:

iodo-cyano-pindolo

MNC:

mononuclear blood cells

References

  1. Ahrens RC, Smith GD (1984) Albuterol: an adrenergic agent for use in the treatment of asthma. Pharmacology, pharmacokinetics and clinical use. Pharmacotherapy 4:105–120

    PubMed  Google Scholar 

  2. Böyum A (1968) A one-stage procedure for isolation of granulocytes and lymphocytes from human blood. Scan J Clin Lab Invest [Suppl] 97:51–89

    Google Scholar 

  3. Brodde O-E, Brinckmann M, Schmemuth R, O'Hara N, Daul A (1985) Terbutaline-induced desensitization of human lymphocyte β2-adrenoceptors. J Clin Invest 76:1096–1101

    PubMed  Google Scholar 

  4. Brodde O-E, Beckerlingh JJ, Michel MC (1987) Human heartadrenoceptors: a fair comparison with lymphocyte beta-adrenoceptors? Trends Pharmacol Sci 8:403–407

    Google Scholar 

  5. Brooks SM, McGowan K, Bernstein IL, Alteman P, Peagler J (1979) Relationship between numbers of beta-adrenergic receptors in lymphocytes and disease severity in asthma. J Allergy Clin Immunol 63:401–406

    PubMed  Google Scholar 

  6. Chuang DM, Costa DM (1979) Evidence for internalization of the recognition site of β-adrenergic receptors during receptor subsensitivity induced by(-)-isoproterenol. Proc Natl Acad Sci USA 76:3024–3028

    PubMed  Google Scholar 

  7. Conolly ME, Greenacre JK (1976) The lymphocyte β-adrenoceptor in normal subjects and patients with bronchial asthma. J Clin Invest 58:1307–1316

    PubMed  Google Scholar 

  8. Conolly ME, Greenacre JK (1977) The beta-adrenoceptor of human lymphocyte and human lung parenchyma. Br J Pharmacol 59:17–23

    PubMed  Google Scholar 

  9. Conolly ME, Greenacre JK, Schofield P (1979) Dose-dependent desensitization of lymphocyte beta-receptor function after long-term culture with isoprenaline. Br J Pharmacol 58:448–449

    Google Scholar 

  10. Conolly ME, Hui KK, Borst S, Jenne JW (1987) Beta adrenergic tachyphylaxis (desensitization) and functional antagonism. In: Jenne JW, Murphy S (eds) Drug therapy for asthma. Marcel Dekker, New York, pp 259–296

    Google Scholar 

  11. Davis C, Conolly ME (1977) Beta-agonist resistence in human bronchial muscle. Clin Sci Mol Med 52:28

    Google Scholar 

  12. Feldman H (1972) Mathematical theory of complex ligandbinding systems: an equilibrium. Anal Biochem 48:317–338

    PubMed  Google Scholar 

  13. Galant SP, Duriseti L, Underwood S, Insel PA (1978) Decreased beta-adrenergic receptors on polymorphonuclear leukocytes after therapy. N Engl J Med 299:933–936

    PubMed  Google Scholar 

  14. Gibson GJ, Greenacre JK, König P, Conolly ME, Pride NB (1978) Use of exercise challenge to investigate possible tolerance to beta-adrenoceptor stimulation in asthma. Br J Dis Chest 72:199–206

    PubMed  Google Scholar 

  15. Gillespie E, Valentine MD, Lichtenstein LM (1974) Cyclic AMP metabolism in asthma. Studies with leukocytes and lymphocytes. J Allergy Clin Immunol 53:27–33

    PubMed  Google Scholar 

  16. Greenacre JK, Schofield P, Conolly ME (1978) Desensitization of the β-adrenoceptor of lymphocytes from normal subjects and asthmatic patients. Br J Clin Pharmacol 5:199–206

    PubMed  Google Scholar 

  17. Harden TK (1983) Agonist induced desensitization of the betaadrenergic receptor linked adenylate cyclase. Pharmacol Rev 35:5–41

    PubMed  Google Scholar 

  18. Harvey JE, Tattersfield AE (1979) Beta-adrenergic responsiveness in asthmatics and atopic non-asthmatic subjects. Thorax 34:416

    Google Scholar 

  19. Kariman K (1980) β-adrenergic receptor binding in lymphocytes from patients with asthma. Lung 158:41–51

    PubMed  Google Scholar 

  20. Lefkowitz RJ, Caron MG (1986) Regulation of adrenergic function by phosphorylation. J Mol Cell Cardiol 18:885–895

    PubMed  Google Scholar 

  21. Meurs H, Koeter GH, Vries K de, Kaufmann HF (1982) The beta-adrenergic system and allergic bronchial asthma: changes in lymphocyte beta-adrenergic receptor number and adenylate cyclase activity after an allergen-induced asthmatic attack. J Allergy Clin Immunol 70:772–780

    Google Scholar 

  22. Miller WC (1978) Long-term beta2 bronchodilator therapy and the question of tolerance. Chest 73 [Suppl]:1000–1001

    PubMed  Google Scholar 

  23. Nahorski SR, Barnett DB (1982) Biochemical assessment of adrenoceptor function and regulation. New directions and clinical relevance. Clin Sci 63:97–105

    PubMed  Google Scholar 

  24. Nelson HS (1982) Beta adrenergic agonists. Chest 82 [Suppl] 335:389

    Google Scholar 

  25. Plummer AL (1978) The development of drug tolerance to β2-adrenergic agonists. Chest 73:949–957

    PubMed  Google Scholar 

  26. Reinhardt D, Zehmisch T, Becker B, Nagel-Hiemke M (1984) Age-dependency of alpha- and beta-adrenoceptors on thrombocytes and lymphocytes of asthmatic and nonasthmatic children. Eur J Pediatr 142:111–116

    PubMed  Google Scholar 

  27. Reinhardt D, Ludwig J, Braun D, Kusenbach G, Griese M (1988) Effects of the antiallergic drug ketotifen on bronchial resistance and beta-adrenoceptor density of lymphocytes in children with exercise-induced asthma. Dev Pharmacol Ther 11:180–188

    PubMed  Google Scholar 

  28. Scatchard G (1949) The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51:660–672

    Google Scholar 

  29. Schuster A, Elsen A, Griese M, Kusenbach G, Reinhardt D (1989) The adrenergic system in lymphocytes from children with cystic fibrosis. Klin Wochenschr 67:799–803

    PubMed  Google Scholar 

  30. Speizer F, Doll ER, Heaf P (1968a) Observations on the recent increase in mortality from asthma. Br Med J 1:335–339

    PubMed  Google Scholar 

  31. Speizer F, Doll ER, Heaf P, Strang LB (1968b) Investigation into the use of drugs proceeding death from asthma. Br Med J 1:339–343

    PubMed  Google Scholar 

  32. Stiles GL, Caron MG, Lefkowitz RJ (1984) β-adrenergic receptors: Biochemical mechanisms of physiological regulation. Physiol Rev 64:661–743

    PubMed  Google Scholar 

  33. Tashkin DP, Conolly ME, Deutsch RI, Hiu KK, Littner M, Scarpace P, Abrass J (1982) Subsensitization of beta-adrenoceptors in airways and lymphocytes of healthy and asthmatic subjects. Ann Rev Respir Dis 125:185–193

    Google Scholar 

  34. Vaisman N, Koren G, Goldstein D, Canny GJ, Tan YK, Soldin S, Pencharz P (1987) Pharmacokinetics of inhaled salbutamol in patients with cystic fibrosis versus healthy young adults. J Pediatr 111:914–917

    PubMed  Google Scholar 

  35. Weber RW, Smith JA, Nelson HS (1982) Aerolized terbutaline in asthmatics: development of subsensitivity with long-term administration. J Allergy Clin Immunol 70:417–422

    PubMed  Google Scholar 

  36. Williams LT, Snyderman R, Lefkowitz RJ (1976) Identification of beta-adrenergic receptors in human leukocytes with3(H)-dehydroalprenolol. J Clin Invest 57:149–155

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schuster, A., Kozlik, R. & Reinhardt, D. Influence of short- and long-term inhalation of salbutamol on lung function and β2-andrenoceptors of mononuclear blood cells in asthmatic children. Eur J Pediatr 150, 209–213 (1991). https://doi.org/10.1007/BF01963569

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01963569

Key words

Navigation